LEAP THERAPEUTICS, INC.

Insiders Leap Therapeutics, Inc.

Equities

LPTX

US52187K2006

Real-time Estimate Cboe BZX Other stock markets 10:51:06 2024-05-01 am EDT			5-day change	1st Jan Change
3.185 ^USD	+2.74%		-3.65%	-23.52%

Apr. 10	Leap Therapeutics, Inc. announced that it expects to receive $39.998476 million in funding from Samsara BioCapital LLC, 683 Capital Management, LLC, Rock Springs Capital Management LP, Gilead Sciences, Inc., Laurion Capital Management LP	CI
Mar. 19	Baird Adjusts Price Target on Leap Therapeutics to $9 From $11, Maintains Outperform Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Leap Therapeutics, Inc. Announces the Promotion of Jason Baum to Chief Scientific Officer, Effective April 1, 2023	23-03-24	CI
Tesla's China sales slow as price-cut boost wanes	23-02-28	RE
Leap Therapeutics, Inc. Appoints Atricia Martin and Christian Richard to Board of Directors	23-01-17	CI
Leap Therapeutics, Inc. Announces Appointment of Richard L. Schilsky, MD to its Board of Directors	22-09-06	CI
Leap Therapeutics, Inc. Resigns Dr. Monica Bertagnolli, as Director	22-08-12	CI
Top Midday Gainers	21-09-16	MT
Leap Therapeutics Announces Management Appointments	20-08-24	CI
Leap Therapeutics Announces Executive Changes, Effect from April 1, 2020	20-03-18	CI
Leap Therapeutics, Inc. and Macrocure Ltd. Announce Management Changes	16-08-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer